Sagentia celebrates new identity and 20th birthday

Scientific Generics Ltd, the Cambridge-headquartered international technology company, has changed its name to Sagentia Ltd. The change of name is part of a fundamental rebranding at the company which celebrates 20 years of successful business this year.

[USPRwire, Tue Oct 24 2006] Scientific Generics Ltd, the Cambridge-headquartered international technology company, has changed its name to Sagentia Ltd. The change of name is part of a fundamental rebranding at the company which celebrates 20 years of successful business this year.

Sagentia’s rebranding programme and 20th anniversary coincide with the appointment of Dr Christopher Masters as non-executive Chairman at Sagentia’s ultimate parent company The Generics Group AG. As part of the rebranding process, The Generics Group AG will change its name to Sagentia Group AG before the year-end.

Major rebranding programme
Sagentia’s name change is the culmination of a major nine month rebranding project at Sagentia involving clients, staff and other stakeholders.
Since its establishment in Cambridge in 1986, Sagentia’s business has grown consistently and has become an international organisation with many clients based outside the UK. Looking to the future, Sagentia’s management is keen to ensure that its global identity helps explain how the company generates value for its clients.

Sagentia’s original name reflected a focus on the development of platform technologies capable of multiple applications. However, over the past 20 years, the word ‘generic’ has come to mean ‘commodity’, particularly in the medical sector where it is specifically associated with unbranded medicines. Sagentia has a strong presence in the medical sector, along with five other global markets. The name change will enable the company to dispel any ambiguities in the marketplace arising from its previous name.

Simon Davey, Sagentia Ltd’s Chief Executive, commented: ‘We believe our new name and brand identity brings clarity to our market position and also our overall corporate proposition; which is to be the company of choice for clients, partners, employees and shareholders who seek a leadership position in the creation of value from technology. But while our brand and name have changed, the underlying principle upon which our business is founded has not. We will continue to lead in the creation of value from technology that will enable our clients to realise better business opportunities.’

Appointment of Group Chairman, and Group Structure
Sagentia Group AG, the rebranded group holding company, will continue to have two principal operating subsidiaries: Sagentia Ltd (the technology consultancy business); and Chord Capital Ltd (the venture management business previously known as Generics Asset Management). Under Swiss law, the change of name of the holding company to Sagentia Group AG requires the formality of a special resolution at the Company’s Extraordinary General Meeting (EGM) to be held on November 16th 2006.
This coincides with the Board’s decision to recommend the appointment of Dr Christopher Masters as Independent Non-Executive Chairman of the Group. The appointment of Dr Masters will be subject to the passing of a special resolution at the same EGM to be held in November. Dr Masters has already started to work with Sagentia’s management team.

Johan Bjorklund the current Chairman, and also Managing Director of the Group's principal shareholder, Catella AB, will remain on the Board as a Non-Executive Director. Martin Frost continues in his position as Managing Director of Sagentia Group AG, the parent company of both Sagentia Ltd and Chord Capital.

--------------------------------------ends--------------------------------------

For more information please contact:

Emma Drake
Public Relations Manager
Emma.drake@sagentia.com
Tel: +44 (0) 1223 875535
Mob: +44 (0) 7795 101779

Andy Matthews
Marketing and PR
mailto:Andy.j.matthews@sagentia.com
Tel: +44 (0) 1223 875251

Note to editors

About Sagentia
Sagentia creates value from technology by developing richer solutions with clients that enable them to realise better business opportunities.
Sagentia operates in six global market sectors – medical, industrial products, consumer products, chemicals, materials & energy, telecoms & media and public sector - developing new technologies, products and services that change the basis of competition. The company also assists business leaders and policy makers to create strategies for technology, innovation and growth.

Sagentia’s resources are situated in state-of-the-art facilities in Cambridge UK, Frankfurt and Stockholm in Europe, Boston and Baltimore in the USA, and Hong Kong and Shanghai in China. The Group is listed on the London Stock Exchange (ti: GEN.L) and has more than 200 employees.

info@sagentia.com

Bookmark this release: Del.icio.us - Digg - Furl - Blinklist - Reddit